Home Products IRIS Vitalis AI Demo Trust Research
TalaStar Digital Health UK Ltd · Private Sector Innovation

WEAN O2 Wearable Enrichment AI-Enabled Neuro-Adaptive Oxygen Therapy

A nurse-led feasibility study to facilitate efficient post-respiratory illness recovery and improve discharge pathways.

Download Submission Pack
WEAN O₂ concept illustration
WEAN O₂ Modular Wearable Air Purification System — concept rendering

A Closed-Loop Respiratory Governor

WEAN-O₂ is a hybrid respiratory support platform designed to enhance post-respiratory illness recovery through intelligent, closed-loop oxygen and ventilation regulation. It functions as a closed-loop respiratory governor: predicting instability using a patient-specific digital twin, optimising oxygen delivery via breath-synchronised micro-dosing, and applying state-dependent neuromodulation to assist hypoventilation or entrain hyperventilation.

Core Objectives
  • Stabilise PaO₂/PaCO₂ balance
  • Reduce oxygen dependence
  • Prevent deterioration and readmissions
  • Improve discharge efficiency
  • Enhance patient independence and quality of life
The Problem
  • Delayed oxygen weaning in post-respiratory patients
  • Instability during discharge transition
  • Recurrent hospital admissions
  • Anxiety-related breathing dysfunction

Modular Wearable Air Purification System

Five modular components connected in series, each independently replaceable and upgradeable.

01
💨
Air Intake
Ultrathin PDMS Filter
02
⚗️
Oxygen Enrichment Chamber
Optional MOF / PDMS Composite
03
🛡️
Microbiome Filtration Unit
Nanofiber Membrane with Antimicrobial Agents
04
❄️
Cooling Fan Module
USB Rechargeable
05
🔋
Control & Battery Module
Power & Control Unit
WEAN O2 prototype system
WEAN O₂ Modular Wearable Air Purification System — 5-component modular architecture

Five Integrated Mechanisms

MECHANISM 01
Preventive Detection of Respiratory Instability

Continuous sensing of SpO₂, respiratory rate, effort, heart rate and optional CO₂ detects early pre-decompensation patterns. A patient-specific digital twin forecasts risk of hypoventilation, hyperventilation, and deterioration before clinical thresholds are breached.

Clinical Effect: Earlier intervention, fewer late escalations, and improved stability during oxygen weaning.
MECHANISM 02
Micro-Dosed, Breath-Synchronised Oxygen Optimisation

Controlled oxygen enrichment and inspiratory micro-dosing improve oxygen efficiency per breath. FiO₂ rate limits protect CO₂ retainers and reduce oxygen waste while improving time-in-target SpO₂.

Clinical Effect: Increased time-in-target SpO₂ with reduced oxygen dependency and improved discharge readiness.
MECHANISM 03
Bidirectional Ventilatory Regulation via Neuromodulation

Phrenic stimulation assists hypoventilation by augmenting diaphragmatic contraction, and entrains hyperventilation by stabilising rhythm and reducing chaotic breathing patterns.

Clinical Effect: Stabilised ventilatory control across both ends of the CO₂ spectrum.
MECHANISM 04
Biosecurity and Airway Protection

HEPA and antimicrobial filtration reduce inhaled pathogen load and support resilience during respiratory outbreaks. Filter integrity is monitored through pressure-drop and remaining-life prediction.

Clinical Effect: Reduced infection risk and safer long-term wearable respiratory support.
MECHANISM 05
Safety Kernel and Graceful Degradation

Hard safety limits, signal integrity checks, and safe fallback modes ensure that automation cannot exceed clinician-defined boundaries. The system degrades safely under faults and prompts escalation when required.

Clinical Effect: Minimised risk of harm from automation with preserved human oversight.

The Navier–Stokes Connection

From Pure Mathematics to Life Support

The same equations whose regularity we seek to prove are the equations that govern the oxygen separation process at the heart of WEAN O₂.

Stokes Flow — Bubble Terminal Velocity

vb = 2r²(ρl − ρg)g / 9μl

When a small gas bubble (radius r) forms at the anode surface, it experiences buoyant force and viscous drag. Using the simplified Stokes formula with a 20% potassium carbonate electrolyte (ρl = 1162 kg/m³, ρg = 1.42 kg/m³, μl = 0.0013 Pa·s) and r = 0.3–0.5 mm, the resulting terminal velocity is approximately 0.175–0.486 m/s.

This implies that for an anode depth of h = 0.05 m, the time required for a bubble to reach the fluid surface is on the order of 0.10–0.28 seconds — enabling rapid, gravity-assisted product self-separation without membranes or external circulation.


12-Month Research Programme

12-Month Research Programme — Private Sector Development

Project Phase M1M2M3M4M5M6 M7M8M9M10M11M12
Project Setup & Governance
Benchtop Feasibility Testing
System Integration & Simulation
Clinical Usability Evaluation
Data Analysis & Synthesis
Dissemination & Next-Stage Planning

Specifications

Full Name
Wearable Enrichment AI-Enabled Neuro-Adaptive Oxygen Therapy
Acronym
WEAN O₂
Study Type
Nurse-Led Feasibility Study
Core Technology
Electrochemical O₂ separation + AI-driven closed-loop delivery (research concept, not yet built)
O₂ Enrichment
Electrochemical pump with selective membrane (no compressor)
Sensing Suite
SpO₂ (PPG), Temperature, Blood Pressure (PTT), Respiratory Rate, IMU
Neuromodulation
External phrenic nerve stimulation (bidirectional)
Safety
Hard FiO₂ caps, CO₂ rebreathing avoidance, thermal limits, fail-safe ambient air
Fluid Dynamics Basis
Stokes flow equations governing buoyancy-driven O₂ bubble separation
Parent Company
TalaStar Digital Health UK Ltd
Principal Investigator
TalaStar Digital Ltd